.png)
A specialist life sciences supply chain consultancy with embedded AI capability built in. Viaclin was built to solve the problems that generalist consultancies cannot. We operate at the intersection of deep supply chain expertise and practical AI integration, providing both hands-on execution and strategic oversight across the full life sciences supply chain.
Clinical and commercial supply chains are managed across siloed teams, resulting in no unified ownership, constant handoff gaps, and compounding risk.
Delayed responses to demand signals, regulatory changes, and manufacturing disruptions. Leaders are forced to act on stale data with limited AI support.
Increasingly complex GMP, FDA, EMA, and ICH requirements demand specialist expertise that most internal teams cannot sustain alone.
We take full enterprise ownership of S&OP.
We deploy advanced forecasting via SAP and planning tools to align clinical demand, commercial rollout, and manufacturing capacity.
The result is optimized buffer stock, eliminated overproduction, and capital that stays where it belongs.
Total ownership from high-tech packaging and strict cross-border logistics to CDMO tech transfers and rigorous global site readiness.
There are no handoffs between siloed teams. We ensure there are no gaps between functions.
We provide our own, out-of-the-box AI agents that act as navigators for both supply professionals and leaders.
Our agents bridge the gap between manual activity and full, risky autonomy.
They provide guidance and insights to improve decision-making, de-risking your supply chain.
Our consultants are senior practitioners with direct experience in pharmaceutical, biotech, and MedTech supply operations, not analysts learning on your time. We are a diverse team located across Europe, the US, and the UK, fully remote and integrated.
Regulatory expertise across EMA, HPRA, and MHRA markets. Clinical supply hubs in Ireland, UK, Germany, and Netherlands.
FDA regulatory fluency. Commercial supply and strategic sourcing coverage across major US pharma clusters.
Post-Brexit import/export specialisms. MHRA-experienced quality and supply chain consultants.